---
title: "Phentolamine - Pheochromocytoma"
sidebar: mydoc_sidebar
permalink: db00692-mesh-d010673-1.html
toc: false 
---


Path ID: `DB00692_MESH_D010673_1`
{% include image.html url="images/db00692-mesh-d010673-1.png" file="db00692-mesh-d010673-1.png" alt="db00692-mesh-d010673-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D010646 | Phentolamine | Drug |
| UniProt:P35368 | Alpha-1B adrenergic receptor | Protein |
| UniProt:P35348 | Alpha-1A adrenergic receptor | Protein |
| UniProt:P25100 | Alpha-1D adrenergic receptor | Protein |
| GO:0042310 | Vasoconstriction | BiologicalProcess |
| HP:0000822 | Hypertension | PhenotypicFeature |
| MESH:D010673 | Pheochromocytoma | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Phentolamine | DECREASES ACTIVITY OF | Alpha-1B Adrenergic Receptor |
| Phentolamine | DECREASES ACTIVITY OF | Alpha-1A Adrenergic Receptor |
| Phentolamine | DECREASES ACTIVITY OF | Alpha-1D Adrenergic Receptor |
| Alpha-1B Adrenergic Receptor | POSITIVELY REGULATES | Vasoconstriction |
| Alpha-1A Adrenergic Receptor | POSITIVELY REGULATES | Vasoconstriction |
| Alpha-1D Adrenergic Receptor | POSITIVELY REGULATES | Vasoconstriction |
| Vasoconstriction | AFFECTS RISK FOR | Hypertension |
| Hypertension | MANIFESTATION OF | Pheochromocytoma |
|---------|-----------|---------|

Comment: Phentolamine primary action is vasodilation due to Î±1 blockade.

Reference: 
  - [https://en.wikipedia.org/wiki/Phentolamine](https://en.wikipedia.org/wiki/Phentolamine)
  - [https://go.drugbank.com/drugs/DB00692#BE0000501](https://go.drugbank.com/drugs/DB00692#BE0000501)
  - [https://en.wikipedia.org/wiki/Pheochromocytoma](https://en.wikipedia.org/wiki/Pheochromocytoma)
